查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1318909

血管損傷治療市場：按損傷、治療、最終用戶分類 - 2023-2030 年全球預測

Vascular Injury Treatment Market by Injury, Treatment, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球血管損傷治療市場預計到2023年將大幅成長至215.1億美元，複合年成長率為13.74%，預計到2030年將達到驚人的530.4億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球血管損傷治療市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球血管損傷治療市場規模及預測為何？

2.在預測期內，COVID-19 對全球血管損傷治療市場的阻礙因素與影響有哪些？

3.在預測期內，全球血管損傷治療市場需要投資哪些產品/細分市場/應用/領域？

4. 你們在全球血管損傷治療市場上的競爭策略是什麼？

5. 全球血管損傷治療市場的技術趨勢和法律規範是什麼？

6.全球血管損傷治療市場主要供應商的市佔率為何？

7. 哪些型態和策略措施被認為適合進入全球血管損傷治療市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 血管損傷手術發生率上升
      • 由於道路事故、割傷和暴力增加，創傷發生率增加
      • 加強與醫院的合作，提供心臟相關疾病的治療方法
    • 抑制因素
      • 血管損傷治療相關的高成本
    • 機會
      • 新興國家醫療旅遊的成長
      • 科技不斷進步
    • 任務
      • 與血管損傷治療相關的副作用
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 按損傷分類的血管損傷治療市場

  • 動脈瘤和假性動脈瘤
  • 動靜脈瘻管
  • 挫傷或內膜瓣
  • 撕裂或截肢
  • 抽搐
  • 血栓形成

第7章 依治療方式分類的血管損傷治療市場

  • 旁路移植術
  • 額外的解剖旁路
  • 外側動脈或靜脈縫合
  • 補片血管成形術
  • 血栓切除術

第8章 血管損傷治療市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第9章 美洲血管損傷治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太血管損傷治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲血管損傷治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-034B5003037D

The Global Vascular Injury Treatment Market is forecasted to grow significantly, with a projected USD 21.51 billion in 2023 at a CAGR of 13.74% and expected to reach a staggering USD 53.04 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Vascular Injury Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Vascular Injury Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Injury, market is studied across Aneurysm & Pseudoaneurysm, Arteriovenous Fistula, Contusion or Intimal Flap, Laceration or Transection, Spasm, and Thrombosis. The Contusion or Intimal Flap is projected to witness significant market share during forecast period.

Based on Treatment, market is studied across Bypass Graft, Extra Anatomic Bypass, Lateral Arteriorrhaphy or Venorrhaphy, Patch Angioplasty, and Thrombectomy. The Patch Angioplasty is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Center and Hospital. The Ambulatory Surgical Center is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Vascular Injury Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Vascular Injury Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vascular Injury Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vascular Injury Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Vascular Injury Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Vascular Injury Treatment Market?

6. What is the market share of the leading vendors in the Global Vascular Injury Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Vascular Injury Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Vascular Injury Treatment Market, by Injury, 2022 vs 2030
  • 4.3. Vascular Injury Treatment Market, by Treatment, 2022 vs 2030
  • 4.4. Vascular Injury Treatment Market, by End-User, 2022 vs 2030
  • 4.5. Vascular Injury Treatment Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of vascular injury surgeries
      • 5.1.1.2. Rise in the occurrence of trauma due to the increase in the road accidents, cuts, violence
      • 5.1.1.3. Increasing number of collaborations by hospital to provide therapeutic solution for heart related diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the vascular injury treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing medical tourism in developing countries
      • 5.1.3.2. Increasing advancement in technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with vascular injury treatment
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Vascular Injury Treatment Market, by Injury

  • 6.1. Introduction
  • 6.2. Aneurysm & Pseudoaneurysm
  • 6.3. Arteriovenous Fistula
  • 6.4. Contusion or Intimal Flap
  • 6.5. Laceration or Transection
  • 6.6. Spasm
  • 6.7. Thrombosis

7. Vascular Injury Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Bypass Graft
  • 7.3. Extra Anatomic Bypass
  • 7.4. Lateral Arteriorrhaphy or Venorrhaphy
  • 7.5. Patch Angioplasty
  • 7.6. Thrombectomy

8. Vascular Injury Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Center
  • 8.3. Hospital

9. Americas Vascular Injury Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Vascular Injury Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Vascular Injury Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. VASCULAR INJURY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR INJURY TREATMENT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2022 VS 2030 (%)
  • FIGURE 5. VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
  • FIGURE 6. VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. VASCULAR INJURY TREATMENT MARKET DYNAMICS
  • FIGURE 9. VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. VASCULAR INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 5. VASCULAR INJURY TREATMENT MARKET SIZE, BY ANEURYSM & PSEUDOANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIOVENOUS FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. VASCULAR INJURY TREATMENT MARKET SIZE, BY CONTUSION OR INTIMAL FLAP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. VASCULAR INJURY TREATMENT MARKET SIZE, BY LACERATION OR TRANSECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. VASCULAR INJURY TREATMENT MARKET SIZE, BY SPASM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 12. VASCULAR INJURY TREATMENT MARKET SIZE, BY BYPASS GRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. VASCULAR INJURY TREATMENT MARKET SIZE, BY EXTRA ANATOMIC BYPASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. VASCULAR INJURY TREATMENT MARKET SIZE, BY LATERAL ARTERIORRHAPHY OR VENORRHAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. VASCULAR INJURY TREATMENT MARKET SIZE, BY PATCH ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 148. VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 149. VASCULAR INJURY TREATMENT MARKET LICENSE & PRICING